16.02
-0.87%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zhejiang Jiuzhou Pharmaceutical Co
Its shares trade on Shanghai under the ticker 603456.SS. It has been listed since 10 October 2014. In the fiscal year to 31 December 2025, it reported revenue of CN¥5.51bn and net income of CN¥730.1m. At that date it held total assets of CN¥10.60bn and shareholders' equity of CN¥8.72bn.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. The company is headquartered in Taizhou, Zhejiang. The company went IPO on 2014-10-10. is a China-based company principally engaged in the research, development, production and sales of chemical Active Pharmaceutical Ingredients (API) and intermediates. The firm mainly operates through two segments, including the New Drug and Intermediates Contract Development and Manufacturing Organization (CDMO) segment and the Specialty APIs and Intermediates segment. The New Drug and Intermediates CDMO segment mainly provides services for innovative medicines of pre-clinical chemical manufacturing and controls (CMC), clinical phases I, II and III, new drug application (NDA) and various stages after going public. The Specialty API and Intermediates segments mainly provides services including patent breakthroughs, production process improvement, drug certificate declaration, and cGMP standard commercial production for patented expired or soon-to-be-expired drugs for global chemical and generic drug manufacturers.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 10 Oct 2014
- Employees
- 4,602
- Website
- jiuzhoupharma.com ↗
Leadership
Pay as last reported
- Ms. Lirong HuaChairman of the Board, since 2014CN¥2.0m
- Mr. Yijiang MeiPresident, Executive Director, since 2016CN¥3.3m
- Mr. Yujie ShaFinance Director, Vice President, Executive Director, since 2021CN¥842,000
- Mr. Huilu LinVice President, Executive Director, Secretary of the Board, since 2014CN¥1.4m
- Mr. Yuanqiang LiVice President, Executive Director, since 2016CN¥1.3m
- Mr. Gong ChenVice PresidentCN¥1.8m
- Ms. Minxia HuangVice PresidentCN¥1.1m
- Mr. Nonggang YangVice PresidentCN¥1.1m
- Mr. Ming XuDirectorCN¥160,000
- Ms. Qi JiangIndependent DirectorCN¥160,000
- Mr. Jicheng LiIndependent DirectorCN¥160,000
- Mr. Lirong YangIndependent Director, since 2024CN¥80,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 94
- Environment
- 99
- Social
- 99
- Governance
- 84
- Direct emissions (scope 1)
- 102,853 t
- Energy emissions (scope 2)
- 224,782 t
- Value chain emissions (scope 3)
- 418,334 t
- Women in the workforce
- 26.89462%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zhejiang Jiuzhou Pharmaceutical employs 4602 full-time staff members globally.
- The company operates in the Health Care sector of China.
- Zhejiang Jiuzhou Pharmaceutical produces active pharmaceutical ingredients and intermediates.
Weaknesses
- The company is headquartered in Taizhou, Zhejiang province.
- Zhejiang Jiuzhou Pharmaceutical went public on 10 October 2014.
- The firm focuses on chemical Active Pharmaceutical Ingredients and intermediates.
Opportunities
- The New Drug and Intermediates CDMO segment provides clinical services.
- Specialty APIs and Intermediates segment serves global patented expired drugs.
- Zhejiang Jiuzhou Pharmaceutical offers asymmetric catalyst and lithium battery materials.
Threats
- The company faces competition in the pharmaceuticals industry sector.
- Zhejiang Jiuzhou Pharmaceutical relies on chemical manufacturing and controls.
- The firm provides services for innovative medicines of pre-clinical stages.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.